DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
15.53
-0.75 (-4.61%)
Jun 18, 2026, 4:00 PM EDT - Market closed
DBV Technologies Revenue
DBV Technologies had revenue of $900.00K in the quarter ending March 31, 2026, with 12.50% growth. This brings the company's revenue in the last twelve months to $5.14M, up 69.44% year-over-year. In the year 2025, DBV Technologies had annual revenue of $5.64M with 35.77% growth.
Revenue (ttm)
$5.14M
Revenue Growth
+69.44%
P/S Ratio
167.57
Revenue / Employee
$35,627
Employees
161
Market Cap
961.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.64M | 1.49M | 35.77% |
| Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
| Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
| Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
| Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
| Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
| Dec 31, 2019 | 14.71M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 369.49M |
| Arbutus Biopharma | 191.45M |
| ARS Pharmaceuticals | 98.99M |
| Xencor | 97.36M |
| Odyssey Therapeutics | 1.06M |
DBVT News
- 12 days ago - DBV Technologies S.A.: DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference - Finanz Nachrichten
- 12 days ago - DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 13 days ago - DBV Technologies S.A.: DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 - Finanz Nachrichten
- 13 days ago - DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 - GlobeNewsWire
- 16 days ago - DBV Technologies S.A.: DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Finanz Nachrichten
- 16 days ago - DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 18 days ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 - Finanz Nachrichten
- 18 days ago - DBV Technologies S.A.: DBV Technologies Announces the Results of its 2026 Combined General Meeting - Finanz Nachrichten